On Wednesday, Shares of Whole Foods Market, Inc. (NASDAQ:WFM), gained 0.40% to $47.72.
Whole Foods Market, stated results for the 12-week second quarter ended April 12, 2015. For the quarter, total sales raised 10% to a record $3.6 billion. Comparable store sales on a constant currency basis raised 3.6%, counting an estimated 50 basis point positive impact from Easter shifting from the third quarter last year to the second quarter this year. Earnings before interest, taxes, depreciation and amortization were $355 million, or 9.7% of sales. Diluted earnings per share were $0.44, a 14% enhance over the preceding year. Results comprise a non-routine supplier credit of $7 million, or $0.01 in diluted earnings per share.
During the quarter, the Company produced $322 million in cash flow from operations and invested $206 million in capital expenditures, resulting in free cash flow of $116 million. In addition, the Company returned $47 million in quarterly dividends to shareholders and repurchased $47 million of common stock, or 0.9 million shares. The Company ended the quarter with total cash and cash equivalents, restricted cash, and investments of about $1.1 billion. Return on invested capital raised 68 basis points to 15%.
Whole Foods Market, Inc. operates as a retailer of natural and organic foods. The company’s stores offer produce and floral, grocery, meat, seafood, bakery, prepared foods and catering, coffee, tea, beer, wine, cheese, nutritional supplements, vitamins, and body care products, in addition to lifestyle products, counting books, pet products, and household products.
Shares of Hewlett-Packard Company (NYSE:HPQ), declined -1.99% to $32.50, during its last trading session.
Hewlett-Packard Company, declared new and improved purpose-built Compute platforms and solutions designed to assist customers leverage all data assets in order to drive business outcomes, such as faster decision making, improved operational efficiency and direct content monetization.
Gartner, Inc. forecasts that 4.9 billion connected “things” will be in use in 2015, up 30 percent from 2014 and will reach 25 billion by 2020. This will cause an exponential enhance in the amount of data, each of which will have a distinct value to the business. As a result, the industry is seeing the emergence of new technologies and architectures — from open source data analytics and database platforms to in-memory databases — built to derive value from data and deliver business outcomes.
HP’s new Compute platforms have been tailored to meet the specific requirements of these data-intensive workloads. These platforms are purpose-built for a range of emerging technologies and applications counting mass content storage, block and file storage, unstructured and real-time analytics, in addition to simple and transactional databases.
The new and improved servers and solutions comprise: HP Apollo 2000; the HP Apollo 4000 Systems family; the HP Big Data Reference Architecture; HP Integrity Superdome X; and the HP ProLiant DL580, DL560 and BL660c Gen9 servers. These servers are designed to optimize capacity and performance scalability, flexibility and cost efficiency with unique designs that address data center space, power and cooling challenges.
Hewlett-Packard Company, together with its auxiliaries, provides products, technologies, software, solutions, and services to individual consumers and small- and medium-sized businesses (SMBs), in addition to the government, health, and education sectors worldwide.
At the end of Wednesday’s trade, Shares of Marathon Oil Corporation (NYSE:MRO), lost -0.53% to $29.81.
Marathon Oil Corporation, stated a first quarter 2015 adjusted net loss of $253 million, or $0.37 per diluted share, not taking into account the impact of certain items not typically represented in analysts’ earnings estimates and that would otherwise affect comparability of results. The stated net loss was $276 million, or $0.41 per diluted share.
Corporate Highlights
Drilling efficiency, additional service cost reductions and capital reallocation enhancing returns
◦ High-specification rigs in Eagle Ford delivering pacesetter spud-to-total depth results of under seven days
◦ Raised year-to-date captured savings from U.S. unconventional drilling and completions service costs to $250 million, or 17 percent, with more predictable
◦ Reallocating more than $25 million of capital to Oklahoma Resource Basins
Rigorous cost control focus
◦ Reduced North America E&P production costs per barrel of oil equivalent (boe) 17% from fourth quarter 2014, and 28% below the year-ago quarter
◦ First quarter workforce reductions predictable to generate annualized net savings of about $100 million.
Marathon Oil Corporation operates as an energy company. It operates in three segments: North America Exploration and Production, International Exploration and Production, and Oil Sands Mining. The North America Exploration and Production segment explores for, produces, and markets crude oil and condensate, natural gas liquids, and natural gas in North America. The International Exploration and Production segment explores for, produces, and markets crude oil and condensate, natural gas liquids, and natural gas in Equatorial Guinea, Ethiopia, Gabon, Kenya, the Kurdistan Region of Iraq, Libya, and the United Kingdom; and produces and markets products manufactured from natural gas, such as liquefied natural gas and methanol in Equatorial Guinea. The Oil Sands Mining segment mines, extracts, and transports bitumen from oil sands deposits in Alberta and Canada; and upgrades the bitumen to produce and market synthetic crude oil and vacuum gas oil.
Finally, AbbVie Inc. (NYSE:ABBV), ended its last trade with 0.13% gain, and closed at $63.94.
AbbVie, will take part in the Bank of America Merrill Lynch 2015 Health Care Conference on Wednesday, May 13, 2015. Richard A. Gonzalez, chairman and chief executive officer, will take part in a question and answer session at 3 p.m. Central time.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products comprise HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
